Symptom Management Implementation of Patient Reported Outcomes in Oncology
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Hassett, MD
Dana-Farber Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Maine Medical Center
Portland, Maine, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
- Brown University Health (formerly Lifespan Cancer Institute)
Providence, Rhode Island, United States
- Baptist Memoiral Healthcare
Memphis, Tennessee, United States
- West Virginia University Medical Center
Morgantown, West Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Jul 2019
- Primary completion
- 31 Mar 2023
- Completion
- 9 Jun 2025
- Last update posted
- 27 Aug 2025
- Registered enrollment
- 42,808
- Registry id
- NCT03850912
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.